13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-08-28 Event 2026-08-25 SEC 0001213900-26-095193 →

BRC Group Holdings, Inc. BIOMERICA INC BMRA

Stake: 10.03% Shares: 460,080 CUSIP: 09061H307 Class: Common Stock, par value $0.08 per share

Item 4 — Purpose of Transaction

(a) - (j) The Purchased Shares were acquired by the Reporting Persons for investment purposes, and such purchases were made in the ordinary course of business of the Reporting Persons. In pursuing such investment purposes, the Reporting Persons may further purchase, hold, vote, trade, dispose or otherwise deal in the Common Stock at times, and in such manner, as they deem advisable to benefit from, among other things, (1) changes in the market prices of the shares of Common Stock; (2) changes in the Issuer's operations, business strategy or prospects; or (3) from the sale or merger of the Issuer. To evaluate such alternatives, the Reporting Persons will closely monitor the Issuer's operations, prospects, business development, management, competitive and strategic matters, capital structure, and prevailing market conditions, as well as other economic, securities markets and investment considerations. Consistent with their investment research methods and evaluation criteria, the Reporting Persons may discuss such matters with the management or Board of Directors of the Issuer (the "Board"), other stockholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit, and other investors. Such evaluations and discussions may materially affect, and result in, among other things, the Reporting Persons (1) modifying their ownership of the Common Stock; (2) exchanging information with the Issuer pursuant to appropriate confidentiality or similar agreements; (3) proposing changes in the Issuer's operations, governance or capitalization; (4) pursuing a transaction that would result in the Reporting Persons' acquisition of all or a controlling interest in the Issuer; or (5) pursuing one or more of the other actions described in subsections (a) through (j) of Item 4 of Schedule 13D. In addition to the information disclosed in this Statement, the Reporting Persons reserve the right to (1) formulate other plans and proposals; (2) take any actions with respect to their investment in the Issuer, including any or all of the actions set forth in subsections (a) through (j) of Item 4 of Schedule 13D; and (3) acquire additional shares of Common Stock or dispose of some or all of the shares of Common Stock beneficially owned by them, in each case in the open market, through privately negotiated transactions or otherwise. The Reporting Persons may at any time reconsider and change their plans or proposals relating to the foregoing. Other than the discussion above, the Reporting Persons do not have any other present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a)-(j) or Item 4 of Schedule 13D except as set forth herein or such as would occur upon completion of any of the actions discussed herein. Private Placement - Board Representative In connection with the acquisition of Purchased Shares by BRPC, BRPC is entitled to appoint a representative to the Issuer's Board of Directors. Registration Rights Agreement BRPC entered into a registration rights agreement with the Issuer whereby the Issuer has agreed to register the Purchased Shares. Engagement Letter Simultaneous with the closing of the transaction, the Issuer entered into an engagement letter (the "Engagement Letter") with B. Riley Securities, Inc., an affiliate of BRC and BRPC ("BRS"). BRS will serve as the Issuer's exclusive financial advisor in connection with the evaluation and potential pursuit of certain strategic transactions. The Engagement Letter has an initial term of 24 months.

Cross-References

Insider Activity (last 365d)
6 transactions
6 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
57 filings by this filer
56 other filings in the data moat
Short Interest · settle 2026-08-14
DTC 3.29
18,333 shares short · -20.5% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2025-12-12 Chin Eric director Award 22,500
2025-12-12 Lu Gary officer Award 40,000
2025-12-12 Irani Zackary S. director, officer Award 52,500
2025-12-12 BARBIERI ALLEN director, officer Award 30,000
2025-12-12 MOATAZEDI DAVID director Award 20,000
2025-12-12 Gary M. Huff director Award 20,000

Other 13D/G Filings on BIOMERICA INC

FiledFormFilerStakeShares
2018-01-05 SC GELBAND ALAN view →

Other Filings by BRC Group Holdings, Inc.

FiledFormIssuerStakeShares
2026-08-07 SCHEDULE 13G MGT CAPITAL INVESTMENTS, INC. view →
2026-05-27 SCHEDULE 13D/A TRANSACT TECHNOLOGIES INC TACT 97.00% 100,010 view →
2025-09-03 SCHEDULE TRANSACT TECHNOLOGIES INC TACT 5.90% 600,010 view →
2025-04-02 SCHEDULE TRANSACT TECHNOLOGIES INC TACT 8.30% 826,745 view →
2025-04-02 SCHEDULE Babcock & Wilcox Enterprises, Inc. BW-PA 13.50% 13,246,373 view →
2024-10-01 SC SYNCHRONOSS TECHNOLOGIES INC view →
2024-07-15 SC Babcock & Wilcox Enterprises, Inc. BW-PA view →
2024-07-02 SC SYNCHRONOSS TECHNOLOGIES INC view →
2023-06-02 SC B. Riley Principal 250 Merger Corp. view →
2023-03-13 SC SYNCHRONOSS TECHNOLOGIES INC view →
2022-11-14 SC Lazydays Holdings, Inc. view →
2022-10-11 SC TRANSACT TECHNOLOGIES INC TACT view →
2022-10-11 SC Lazydays Holdings, Inc. view →
2022-07-18 SC Arena Group Holdings, Inc. AREN view →
2022-07-07 SC Lazydays Holdings, Inc. view →
2022-06-10 SC QUANTUM CORP /DE/ QMCO view →
2022-04-14 SC TRANSACT TECHNOLOGIES INC TACT view →
2022-03-15 SC SYNCHRONOSS TECHNOLOGIES INC view →
2022-02-25 SC Arena Group Holdings, Inc. AREN view →
2022-02-16 SC Arena Group Holdings, Inc. AREN view →
Showing 20 of 56

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →